FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

9310211000001100: Simvastatin 40mg / Ezetimibe 10mg tablets 28 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
30681101000001113 Simvastatin 40mg / Ezetimibe 10mg tablets 28 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
30681201000001118 Simvastatin 40mg / Ezetimibe 10mg tablets 28 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


5 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Simvastatin 40mg / Ezetimibe 10mg tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Simvastatin 40mg / Ezetimibe 10mg tablets 28 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Simvastatin 40mg / Ezetimibe 10mg tablets 28 tablet Is pack of Product containing precisely ezetimibe 10 milligram and simvastatin 40 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Simvastatin 40mg / Ezetimibe 10mg tablets 28 tablet Has active ingredient Simvastatin false Inferred relationship Existential restriction modifier
Simvastatin 40mg / Ezetimibe 10mg tablets 28 tablet Has active ingredient Ezetimibe false Inferred relationship Existential restriction modifier
Simvastatin 40mg / Ezetimibe 10mg tablets 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Simvastatin 40mg / Ezetimibe 10mg tablets 28 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Simvastatin 40mg / Ezetimibe 10mg tablets 28 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Simvastatin 40mg / Ezetimibe 10mg tablets 28 tablet Has VMP Product containing precisely ezetimibe 10 milligram and simvastatin 40 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Simvastatin 40mg / Ezetimibe 10mg tablets 28 tablet Has specific active ingredient Ezetimibe true Inferred relationship Existential restriction modifier
Simvastatin 40mg / Ezetimibe 10mg tablets 28 tablet Has specific active ingredient Simvastatin true Inferred relationship Existential restriction modifier
Simvastatin 40mg / Ezetimibe 10mg tablets 28 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Simvastatin 40mg / Ezetimibe 10mg tablets (Accord Healthcare Ltd) 28 tablet 2 x 14 tablets Is a True Simvastatin 40mg / Ezetimibe 10mg tablets 28 tablet Inferred relationship Existential restriction modifier
Inegy 10mg/40mg tablets (Organon Pharma (UK) Ltd) 28 tablet 4 x 7 tablets Is a True Simvastatin 40mg / Ezetimibe 10mg tablets 28 tablet Inferred relationship Existential restriction modifier
Inegy 10mg/40mg tablets (CST Pharma Ltd) 28 tablet Is a True Simvastatin 40mg / Ezetimibe 10mg tablets 28 tablet Inferred relationship Existential restriction modifier
Inegy 10mg/40mg tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Is a True Simvastatin 40mg / Ezetimibe 10mg tablets 28 tablet Inferred relationship Existential restriction modifier
Inegy 10mg/40mg tablets (Waymade Healthcare Plc) 28 tablet Is a True Simvastatin 40mg / Ezetimibe 10mg tablets 28 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start